Galapagos GAAP EPS of Euro4.87, revenue of Euro1.11B; introduces Q1 and FY26 outlook
Source: SeekingAlpha
2026-02-23 23:32:56 ET
More on Galapagos
- Galapagos: Pivoting From Clinical Risk To Strategic Capital Allocation
- Galapagos meets primary goal in phase 3-enabling study for rare autoimmune disease asset
- Seeking Alpha’s Quant Rating on Galapagos
- Historical earnings data for Galapagos
- Financial information for Galapagos
Read the full article on Seeking Alpha
For further details see:
Galapagos GAAP EPS of €4.87, revenue of €1.11B; introduces Q1 and FY26 outlook
Galapagos NV
NASDAQ: GLPG
GLPG Trading
2.76% G/L:
$33.69 Last:
31,805 Volume:
$33.29 Open:
GLPG Latest News
GLPG Stock Data
$2,234,899,163
48,533,193
0.1%
30
N/A
Biotechnology & Life Sciences
Healthcare
BE
Mechelen
